Patient-Focused Business Solutions
for Biopharmaceutical and
Healthcare Industry
Patient-Focused Business Solutions
for Biopharmaceutical and
Healthcare Industry
Our Framework
Understanding the patient’s experience – of their condition and its treatment – is essential in medical product development and clinical care
Mission
Our mission is to support innovation, growth, and improved outcomes in the biopharmaceutical, medical technology, and healthcare industry through a focus on the patient’s experience. Consergo blends scientific, regulatory, and corporate expertise to deliver effective patient-focused business solutions to our clients.
Approach
Consergo leverages our industry experts to advise biopharmaceutical and healthcare companies on how to understand, drive, and improve the patient experience in the context of meeting critical business imperatives
Why patient experience is important
Patient Experience
Adds to a full understanding of program strengths and risks
Increase likelihood of success
Evaluating how treatments impact patient experiences, such as signs, symptoms, physical functioning, and limitations in daily activities, is critical for a full assessment of medical product effectiveness and safety
Increase likelihood of success
Adds to a full understanding of program strengths and risks
Increase likelihood of success
Demonstrating a benefit on the patient’s experience can substantially increase the likelihood of global regulatory and commercial success
Adds to a full understanding of program strengths and risks
Adds to a full understanding of program strengths and risks
Adds to a full understanding of program strengths and risks
Private Equity and Investment Firms: Biotechnology and pharmaceutical investors needs evaluation of all aspects of a development program to understand the strengths and risks associated with a new product. This includes an evaluation of how patient experiences are incorporated in clinical trials
Consergo Services
In-licensing Services
Strategic Support Services
Out-licensing Services
Support private equity and biopharma company investors in identifying strengths and limitations regarding patient experience strategy.
Out-licensing Services
Strategic Support Services
Out-licensing Services
Support smaller companies to optimize their patient experience strategy when preparing for partnership with larger company or discussions with investors; outline the regulatory and commercial considerations to take a product to market.
Strategic Support Services
Strategic Support Services
Strategic Support Services
Strategic communication and Meeting Support with regulators and other healthcare stakeholders.
Senior advisory assistance with:
Advisory committee meeting, Scientific advice, EOP2, among others.
Regulatory Innovation Support: ISTAND, CPIM, EMA ITF, and more.